Lombard Medical, Inc. announced preliminary revenue for the fourth quarter and full year 2015. For the fourth quarter, the company reported revenue of $2.9 million.

For the full year, revenue was $15.1 million. Revenue represents growth of 14% over 2014 and 18% on a constant currency basis.

The company also announced that it is executing a series of initiatives focused on allocating its financial and human resources to support the launch of two important new technologies in the first half of 2016. The company has increased the size of its direct sales force in Germany and the UK to support the European launch of the Altura AAA product line and the Aorfix IntelliFlex LP delivery system. The Altura product will be launched in these two geographies followed by a broader international roll out later in 2016. Another commercial priority will be the launch of the IntelliFlex LP Delivery System following U.S. FDA regulatory approval. A submission was made to the FDA in December 2015 and is currently under review.